Methylated DNA binding domain protein 2 (MBD2) coordinately silences gene expression through activation of the microRNA hsa-mir-496 promoter in breast cancer cell line.
Methylated DNA binding protein 2 (MBD2) binds methylated promoters and suppresses transcription in cis through recruitment of a chromatin modification repressor complex. We show here a new mechanism of action for MBD2: suppression of gene expression indirectly through activation of microRNA hsa-mir-...
Main Authors: | Sebastian Alvarado, Joanne Wyglinski, Matthew Suderman, Stephen A Andrews, Moshe Szyf |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3812180?pdf=render |
Similar Items
-
The structure of the methyl-binding domain of MBD2, and studies of the MBD:DNA interactions
by: Lillie, Kirsten L.
Published: (2006) -
Methylation-mediated silencing and tumour suppressive function of <it>hsa-miR-124 </it>in cervical cancer
by: le Sage Carlos, et al.
Published: (2010-06-01) -
DNA methylation directs genomic localization of Mbd2 and Mbd3 in embryonic stem cells
by: Sarah J Hainer, et al.
Published: (2016-11-01) -
MBD2 and MBD3: elusive functions and mechanisms
by: Roberta eMenafra, et al.
Published: (2014-12-01) -
Salivary microRNAs (hsa-miR-200a, hsa-miR-125a and hsa- miR-93) in relation to age, gender and histopathological parameters.
by: Shaimaa H Mudhir, et al.
Published: (2014-12-01)